| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protara Therapeutics, Inc. (TARA) has 14 insiders with recent SEC Form 4 filings, including 11 buys and 14 sells. TARA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 524.0K | $2.73M | - | |
| CFO | 175.0K | $910.9K | - | |
| Other | 158.0K | $822.4K | - | |
| Other | 94.8K | $493.6K | - | |
| Other | 76.0K | $395.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | Opaleye Management Inc.59 | 10% Owner | Sell | 15,054 | $2.92 | $44,007.97 | -6.3% | -28.1% | +8.2% | |
| May 22, 2024 | Opaleye Management Inc.59 | 10% Owner | Sell | 42,800 | $3.05 | $130,434.45 | -0.9% | -26.4% | +6.0% | |
| May 17, 2024 | Opaleye Management Inc.59 | 10% Owner | Sell | 70,885 | $3.25 | $230,325.63 | -1.4% | -33.7% | +3.2% | |
| May 10, 2024 | Opaleye Management Inc.59 | 10% Owner | Sell | 182,300 | $3.11 | $566,950.60 | -3.6% | -36.7% | +8.0% | |
| Dec 30, 2022 | Opaleye Management Inc.59 | 10% Owner | Sell | 15,473 | $2.71 | $41,948.85 | -0.6% | +15.1% | -30.0% | |
| Sep 15, 2022 | Opaleye Management Inc.59 | 10% Owner | Buy | 23,900 | $3.93 | $93,808.00 | +0.4% | -22.8% | -52.1% | |
| Aug 11, 2022 | Shefferman Jesse | CEO And President | Buy | 9,065 | $3.84 | $34,809.60 | +1.0% | -29.9% | -31.9% | |
| Jun 30, 2022 | Beshar Luke M | Director | Buy | 10,000 | $3.10 | $31,000.00 | +5.3% | +21.8% | -18.4% | |
| Apr 8, 2022 | Opaleye Management Inc.59 | 10% Owner | Buy | 10,136 | $4.78 | $48,486.88 | +0.2% | -34.7% | -41.4% | |
| Mar 14, 2022 | Beshar Luke M | Director | Buy | 10,000 | $4.25 | $42,500.00 | +5.6% | -27.1% | -26.1% |